johnson & johnson
\n<\/h3>\n
People may need annual COVID-19 vaccine shots, Johnson & Johnson CEO says
\n<\/h2>\n
Johnson & Johnson files for emergency approval of single-dose COVID vaccine
\n<\/h2>\n
Johnson & Johnson could deliver 100 million COVID vaccines by June
\n<\/h2>\n
Johnson & Johnson’s one-shot COVID vaccine comes up short
\n<\/h2>\n
Johnson & Johnson has socked away $3.9 billion to help cover the costs of thousands of lawsuits it’s facing over accusations that its baby powder is laced with asbestos.<\/p>\n
The pharmaceutical giant revealed its 2020 litigation expenses in a Monday regulatory filing, saying the money was “primarily associated with talc related reserves and certain settlements.”<\/p>\n
Some 25,000 plaintiffs have filed lawsuits against Johnson & Johnson related to its talc-based baby powder, according to the filing, many of whom claim they got cancer after using the product. <\/p>\n
The New Jersey-based company has faced baby powder safety concerns since a 2018 Reuters investigation found it knew for decades that asbestos \u2014 a toxic substance that can cause cancer when inhaled \u2014 was mixed in with the talc.<\/p>\n
A Missouri court ordered the company last year to pay about $2.1 billion in damages to 22 women who linked their ovarian cancer to its products in a case that J&J is appealing to the US Supreme Court.<\/p>\n
“The company continues to believe that it has strong legal grounds for the appeal of this verdict, as well as other verdicts that it has appealed,” J&J said in the Monday filing.<\/p>\n
A New York court in November awarded $120 million to a Brooklyn woman who got cancer that she blamed on asbestos exposure from using J&J’s baby powder.<\/p>\n
The company announced last May that it would stop selling its iconic talc-based Johnson’s Baby Powder in the US and Canada. J&J attributed the decision to changing consumer habits as well as “misinformation around the safety of the product and a constant barrage of litigation advertising.”<\/p>\n